Dual-action obesity drug rewires brain circuits for appetite.
Where this comes from
- Record sourced from PubMed, PMID 38750199.
- Also identified by DOI 10.1038/d41586-024-01352-6 and PMC identifier 11957427.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A two-in-one drug that modulates neural pathways involved in appetite and reward might prove to be more effective and longer lasting than current weight-loss drugs on the market.
Medical subject headings
- Appetite
- Obesity